| New evidence for the therapeutic potential of curcumin to treat nonalcoholic fatty liver disease in humans ME Inzaugarat, E De Matteo, P Baz, D Lucero, CC García, ... PLoS One 12 (3), e0172900, 2017 | 69 | 2017 |
| Hepatic lipase activity is increased in non‐alcoholic fatty liver disease beyond insulin resistance V Miksztowicz, D Lucero, V Zago, L Cacciagiú, G Lopez, ... Diabetes/metabolism research and reviews 28 (6), 535-541, 2012 | 64 | 2012 |
| Pro-inflammatory and atherogenic circulating factors in non-alcoholic fatty liver disease associated to metabolic syndrome D Lucero, V Zago, GI López, M Graffigna, H Fainboim, V Miksztowicz, ... Clinica Chimica Acta 412 (1-2), 143-147, 2011 | 63 | 2011 |
| A new equation based on the standard lipid panel for calculating small dense low-density lipoprotein-cholesterol and its use as a risk-enhancer test M Sampson, A Wolska, R Warnick, D Lucero, AT Remaley Clinical Chemistry 67 (7), 987-997, 2021 | 55 | 2021 |
| Nonalcoholic fatty liver disease associated with metabolic syndrome: Influence of liver fibrosis stages on characteristics of very low-density lipoproteins D Lucero, V Miksztowicz, G Gualano, C Longo, G Landeira, E Álvarez, ... Clinica chimica acta 473, 1-8, 2017 | 40 | 2017 |
| Does non-alcoholic fatty liver impair alterations of plasma lipoproteins and associated factors in metabolic syndrome? D Lucero, V Zago, GI López, M Graffigna, GH López, H Fainboim, ... Clinica Chimica Acta 412 (7-8), 587-592, 2011 | 39 | 2011 |
| Increased cholesterol efflux capacity in metabolic syndrome: Relation with qualitative alterations in HDL and LCAT D Lucero, D Sviridov, L Freeman, GI López, E Fassio, AT Remaley, ... Atherosclerosis 242 (1), 236-242, 2015 | 38 | 2015 |
| Atherogenic lipoproteins in subclinical hypothyroidism and their relationship with hepatic lipase activity: response to replacement treatment with levothyroxine G Brenta, G Berg, V Miksztowicz, G Lopez, D Lucero, C Faingold, ... Thyroid 26 (3), 365-372, 2016 | 36 | 2016 |
| Predominance of large VLDL particles in metabolic syndrome, detected by size exclusion liquid chromatography D Lucero, V Zago, GH López, L Cacciagiú, GI López, R Wikinski, ... Clinical biochemistry 45 (4-5), 293-297, 2012 | 36 | 2012 |
| Circulating very-low-density lipoprotein characteristics resulting from fatty liver in an insulin resistance rat model V Zago, D Lucero, EV Macri, L Cacciagiú, CA Gamba, V Miksztowicz, ... Annals of Nutrition and Metabolism 56 (3), 198-206, 2010 | 34 | 2010 |
| Role of SN1 lipases on plasma lipids in metabolic syndrome and obesity V Miksztowicz, L Schreier, M McCoy, D Lucero, E Fassio, J Billheimer, ... Arteriosclerosis, thrombosis, and vascular biology 34 (3), 669-675, 2014 | 33 | 2014 |
| Alterations in triglyceride rich lipoproteins are related to endothelial dysfunction in metabolic syndrome D Lucero, GI López, S Gorzalczany, M Duarte, EG Ballerga, J Sordá, ... Clinical biochemistry 49 (12), 932-935, 2016 | 25 | 2016 |
| Overproduction of altered VLDL in an insulin-resistance rat model: Influence of SREBP-1c and PPAR-α D Lucero, V Miksztowicz, V Macri, GH López, S Friedman, G Berg, V Zago, ... Clínica e Investigación en Arteriosclerosis 27 (4), 167-174, 2015 | 25 | 2015 |
| Interleukin 10 promotes macrophage uptake of HDL and LDL by stimulating fluid-phase endocytosis D Lucero, P Islam, LA Freeman, X Jin, M Pryor, J Tang, HS Kruth, ... Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2020 | 22 | 2020 |
| Supplementation with n-3, n-6, n-9 fatty acids in an insulin-resistance animal model: does it improve VLDL quality? D Lucero, C Olano, M Bursztyn, C Morales, A Stranges, S Friedman, ... Food & function 8 (5), 2053-2061, 2017 | 22 | 2017 |
| Role of HDL in neutralizing the VLDL effect on endothelial dysfunction V Zago, S Gorzalczany, D Lucero, C Taira, L Schreier Microvascular Research 89, 153-158, 2013 | 18 | 2013 |
| Adiponectin predicts MMP‐2 activity independently of obesity V Miksztowicz, N Fernandez Machulsky, D Lucero, E Fassio, L Schreier, ... European Journal of Clinical Investigation 44 (10), 951-957, 2014 | 15 | 2014 |
| Transgelin: a new gene involved in LDL endocytosis identified by a genome-wide CRISPR-Cas9 screen D Lucero, O Dikilitas, MM Mendelson, Z Aligabi, P Islam, EB Neufeld, ... Journal of Lipid Research 63 (1), 2022 | 11 | 2022 |
| Effect of dietary calcium (Ca) on body composition and Ca metabolism during growth in genetically obese (β) male rats C Marotte, A Weisstaub, G Bryk, MC Olguin, M Posadas, D Lucero, ... European journal of nutrition 52, 297-305, 2013 | 10 | 2013 |
| Fetal and postnatal zinc restriction: Sex differences in metabolic alterations in adult rats FMG Abregú, MN Gobetto, A Castañón, D Lucero, C Caniffi, R Elesgaray, ... Nutrition 65, 18-26, 2019 | 9 | 2019 |
